Metronomia wishes you - our customers, partners and visitors - a prosperous and Happy New Year 2012.
We are looking forward to continuing our successfull collaboration in 2012.
Today Metronomia has delivered the statistical report for an indirect comparison of data from a single arm trial in oncology with a historical dataset based on ...
Today a multinational pharmaceutical customer awarded a critical market access trial in COPD to Metronomia.
It' the first time that we at Metronomia see more eCRF project being abwarded to Metronomia than paper-CRF trials.
On the 5th of July, Metronomia spent a day working in an asylum-seekers' hostel in Munich.
Metronomia is sponsoring the "European Clinical Data Forum", 24 - 25 May 2011 in Munich, Germany.This event bundles two conferences: "eClinical Trials" and "Clinical Data Management", both representing Metronomia’s core business. We are looking forward to welcome you at our booth!
Read more about this event: http://www.arena-international.com
Metronomia is providing monitoring, data management and statistical services for a randomized phase II study with innovative stem cell therapy in patients suffering from peripheral arterial occlusive disease.
During the last three months contracts with three new bio-pharmaceutical and biotech customers were signed. These customers develop therapies mainly in oncology and dermatology (amongst other indications).
This month significant repeat business was generated: statistical and programming services for four international clinical trials was awarded to Metronomia by one of our long term customers, a global pharmaceutical company.